Crispin Moyo

Multi-Country Analysis of Treatment Costs for HIV/AIDS (MATCH): Facility-Level ART Unit Cost Analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia

Elya Tagar, Maaya Sundaram, Kate Condliffe et al. · PLoS ONE · 2014 · 121 citations · Full text

Public Affairs, Health Policy, Pharmacoeconomics +17

Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trial

Risa M. Hoffman, Crispin Moyo, Kelvin Balakasi et al. · The Lancet Global Health · 2021 · 82 citations · Full text

Public Health, Community Health, Infectious Disease Control +17

Adherence to antiretroviral therapy (ART) during the early months of treatment in rural Zambia: influence of demographic characteristics and social surroundings of patients

Yuri Sasaki, Kazuhiro Kakimoto, Christopher Dube et al. · Annals of Clinical Microbiology and Antimicrobials · 2012 · 59 citations · Full text

Public Health, Community Health, Health Sciences +17

Community-based delivery of HIV treatment in Zambia: costs and outcomes

Brooke E Nichols, Refiloe Cele, Lise Jamieson et al. · AIDS · 2020 · 47 citations · Full text

Public Health, Community Health, Pharmacoeconomics +17

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

James Hakim, Cissy Kityo, Anne Hoppé et al. · The Lancet Infectious Diseases · 2017 · 41 citations · Full text

Pharmacy, Infectious Disease Control, Pharmacotherapy +17